antibody

Documents about antibody

• A Bayesian modelling framework to improve antibody titer estimation applied to RSV dilution series data.#381020NCBI PubMed Central
• Prevalence of Protective Measles Virus Antibody Levels in Umbilical Cord Blood Samples in Catalonia, Spain#383782CiNii
• Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease#405170ClinicalTrials.gov
• Reconstruction of historical malaria transmission in Senegal using multiplex serocatalytic models#406556PLOS
• Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab#432834ClinicalTrials.gov
• Unexpected Reactivity of 1,3,4-Thiadiazole-N-oxides with Strained Alkynes Enables Enhanced Antibody Loading#476108HAL (France)
• OPTIMIZING ANTIBODY-TARGETED NANOPARTICLES FOR SAFE, EFFICIENT ORGAN- AND CELL-TYPE-SPECIFIC DELIVERY#637479ScholarlyCommons at Penn
• Photocleavable DNA barcode-antibody conjugates allow sensitive and multiplexed protein analysis in single cell#643773Harvard DASH
• From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilars.#645442NCBI PubMed Central
• CIR-DDG: backbone-agnostic residual correction of antibody-antigen affinity changes with explicit cross-chain geometry#779466arXiv (OAI Expanded)
• CIR-DDG: backbone-agnostic residual correction of antibody-antigen affinity changes with explicit cross-chain geometry#780841arXiv (All)
• Nirsevimab for respiratory syncytial virus prevention: A comprehensive product review#784677Europe PMC
• PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma#844719ClinicalTrials.gov
• External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL#849597ClinicalTrials.gov
• Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)#854762ClinicalTrials.gov
• A Real-World Study of Bispecific Antibodies in Multiple Myeloma#855677ClinicalTrials.gov
• Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)#858230ClinicalTrials.gov
• Antibody and Safety Study of 6 Doses of NicVAX in Smokers#860937ClinicalTrials.gov
• Biorepository and Registry for Plasma Exchange Patients#871790ClinicalTrials.gov
• Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis#888537ClinicalTrials.gov
• The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer#888591ClinicalTrials.gov
• PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer#889180ClinicalTrials.gov
• Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy#892376ClinicalTrials.gov
• A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates#834079ClinicalTrials.gov
• QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy#872863ClinicalTrials.gov
• A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer#879717ClinicalTrials.gov
• Trial Watch - bispecific T cell engagers and higher-order multispecific immunotherapeutics#4628Europe PMC
• The making of multispecific immunoglobulins - a clinical perspective#4735Europe PMC
• A brain-persistent DDR2-degrading antibody reverses Alzheimer's pathologies by restoring brain fluid dynamics and metabolic clearance#13916bioRxiv / medRxiv
• BOAT: Navigating the Sea of In Silico Predictors for Antibody Design via Multi-Objective Bayesian Optimization#14024arXiv CS
• Investigating antibody cross-reactivity and transmission dynamics of alphaviruses and flaviviruses using a multiplex serological assay.#25578NCBI PubMed Central
• Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes#123638ClinicalTrials.gov
• ASO-based PKM splice-switching therapy increases anti-CTLA-4 antibody efficacy in pancreatic ductal adenocarcinoma#125805Europe PMC
• Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis#125919ClinicalTrials.gov
• B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency#160180ClinicalTrials.gov
• The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects#195407ClinicalTrials.gov
• Trial watch: antibody-drug conjugates in cancer therapy#205878HAL (France)
• Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen#250339HAL (France)
• Intraoperative pain sensitivity and aqueous humor inflammatory cytokine profiles in hepatitis C virus antibody-positive cataract patients.#255152NCBI PubMed Central
• Antibody-Drug Conjugates for Locally Advanced and Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.#255337NCBI PubMed Central
• Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer#256891ClinicalTrials.gov
• Clinical data for primary immunodeficiency patients#260345Rīga Stradiņš University Institutional Repository Dataverse Dataverse OAI Archive
• Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV#283100ClinicalTrials.gov
• A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)#290849ClinicalTrials.gov
• Characterization of HLA-restricted GAD65-specific CD8+ T cell responses in patients with GAD65 antibody-associated neurological disorders#296491bioRxiv / medRxiv
• Serological Responses to Adjuvanted Versus Non-adjuvanted Influenza Vaccines Among People With HIV: a Randomized Clinical Trial#303572ClinicalTrials.gov
• Killer Peptide: an antibody-derived self-assembling peptide bridging antimicrobial and host-defense mechanisms.#305203NCBI PubMed Central
• Antibody response after feline panleukopenia virus vaccination in kittens with and without intestinal parasites#305465Open Access LMU
• Nouvelle classe d'anticorps thérapeutiques ciblant la destruction des antigènes dans les lysosomes#308209HAL (France)
• Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myeloma#320318IRIS